Amelioration of metabolic syndrome by metformin associates with reduced indices of low-grade inflammation independently of the gut microbiota.

导出 OA

翻译打印收藏纠错

作者： Aneseh,Adeshirlarijaney ^[1] ; Jun,Zou ^[1] ; Hao Q,Tran ^[1] ; Benoit,Chassaing ^[1] ; Andrew T,Gewirtz ^[2]

作者单位： Institute for Biomedical Sciences, Georgia State University, Atlanta, Georgia. ^[1] Neuroscience Institute, Georgia State University, Atlanta, Georgia. ^[2]

关键词 antibiotics germ free high-fat diet metabolic syndrome metformin microbiota steatosis

主题词氨苄西林(Ampicillin);动物(Animals);抗菌药(Anti-Bacterial Agents);脂肪肝(Fatty Liver);无菌生物(Germ-Free Life);高血糖症(Hyperglycemia);降血糖药(Hypoglycemic Agents);炎症(Inflammation);肝(Liver);二甲双胍(Metformin);小鼠(Mice);新霉素(Neomycin);肥胖症(Obesity)

DOI 10.1152/ajpendo.00245.2019

PMID 31573841

发布时间 2024-04-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

American journal of physiology. Endocrinology and metabolism

2019年317卷6期

E1121-E1130页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Amelioration of metabolic syndrome by metformin associates with reduced indices of low-grade inflammation independently of the gut microbiota.

American journal of physiology. Endocrinology and metabolism

相似文献

American journal of physiology. Endocrinology and metabolism

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Amelioration of metabolic syndrome by metformin associates with reduced indices of low-grade inflammation independently of the gut microbiota.

American journal of physiology. Endocrinology and metabolism

相似文献

American journal of physiology. Endocrinology and metabolism

相关期刊

检索历史清除